1. MARKETS
  2. SECTOR : PHARMACEUTICALS & BIOTECHNOLOGY
  3. INDUSTRY : MAJOR PHARMACEUTICALS
  4. RENOVORX INC

RenovoRx Inc

XNAS: RNXT

Download real time

0.97 0.01 (1.04%)

42.60% Fall from 52W High

14,471 XNAS Volume

XNAS 19 Mar, 2025 5:30 PM (EDT)

Watchlist

Portfolio

Share
5S
10W
4O
1T
34.5

Market Cap

Below industry Median
-3.8

PE TTM

Negative PE TTM
161.6

PEG TTM

PEG TTM is much higher than 1
4.9

Price to Book

Below industry Median
0.1

Beta 1Year

Very Low volatility


Insider Trading disclosures for RenovoRx Inc

The latest disclosure was made by Kirsten Angela Macfarlane in RenovoRx Inc where a trade of 25,099 Stock Options (right to buy) done was reported to US exchanges on Oct. 1, 2024.

Insider trading is the trading of a company’s securities by individuals with access to confidential or material non-public information about the company. A company is required to report trading by corporate officers, directors, or other company members with significant access to privileged information to the Securities and Exchange Commission (SEC).

Client Name Client Category Action Reported to Exchange Quantity Post Transaction Holding Traded % Avg. Price Value Security Type
Kirsten Angela Macfarlane Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Oct 2024 25,099 25,099 - - Stock Options (right to buy)
Robert J. Spiegel Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Oct 2024 25,099 25,099 - - Stock Options (right to buy)
Laurence J. Marton Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Oct 2024 25,099 25,099 - - Stock Options (right to buy)
Una S. Ryan Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Oct 2024 25,099 25,099 - - Stock Options (right to buy)
Leesa Gentry Chief Clinical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 06 Mar 2024 190,000 190,000 - - Options
B. Ronald Kocak VP, Controller and PAO Grant, award, or other acquisition of securities at price $ 0.00 per share. 09 Feb 2024 15,000 15,000 - - Options
J. Marton Laurence Director Purchase of securities on an exchange or from another person at price $ 0.00 per share. 26 Jan 2024 8,196 8,196 - - Warrants
R. Bagai Shaun Director, Chief Executive Officer Purchase of securities on an exchange or from another person at price $ 0.00 per share. 26 Jan 2024 40,983 40,983 - - Warrants
Marton Laurence J. Director Purchase of securities on an exchange or from another person at price $ 0.00 per share. 26 Jan 2024 8,196 33,634 - - Common Stock
J. Robert Spiegel Director Purchase of securities on an exchange or from another person at price $ 0.00 per share. 26 Jan 2024 40,983 40,983 - - Warrants
Agah Ramtin Director, Chief Medical Officer Purchase of securities on an exchange or from another person at price $ 0.00 per share. 26 Jan 2024 40,983 40,983 - - Warrants
Ramtin Agah Director, Chief Medical Officer Purchase of securities on an exchange or from another person at price $ 0.00 per share. 26 Jan 2024 40,983 47,460 - - Common Stock
Macfarlane Angela Kirsten Director Purchase of securities on an exchange or from another person at price $ 0.00 per share. 26 Jan 2024 40,983 40,983 - - Warrant Shares
R. Shaun Bagai Director, Chief Executive Officer Purchase of securities on an exchange or from another person at price $ 0.00 per share. 26 Jan 2024 40,983 292,540 - - Common Stock
Robert Spiegel J. Director Purchase of securities on an exchange or from another person at price $ 0.00 per share. 26 Jan 2024 40,983 40,983 - - Common Stock
Kirsten Macfarlane Angela Director Purchase of securities on an exchange or from another person at price $ 0.00 per share. 26 Jan 2024 40,983 40,983 - - Common Stock
Angela Gill Nelms Chief Operating Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 19 Jan 2024 125,132 125,132 - - Stock Option
Agah Ramtin Director, Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 19 Jan 2024 28,424 28,424 - - Stock Option
Nelms Angela Gill Chief Operating Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 19 Jan 2024 33,768 33,768 - - Stock Option
Bagai R. Shaun Director, Chief Executive Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 19 Jan 2024 66,973 66,973 - - Stock Option
Agah Ramtin Director, Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 19 Jan 2024 125,132 125,132 - - Stock Option
R. Shaun Bagai Director, Chief Executive Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 19 Jan 2024 250,263 250,263 - - Stock Option
Ramtin Agah Director, Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 15 Mar 2023 65,000 65,000 - - Employee Stock Option (right to buy)
Angela Gill Nelms Chief Operating Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 15 Mar 2023 32,500 32,500 - - Employee Stock Option (right to buy)
Shaun R. Bagai Director, CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 15 Mar 2023 130,000 130,000 - - Employee Stock Option (right to buy)
Una S. Ryan Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Oct 2022 25,099 25,099 - - Stock Option (right to buy)
Laurence J. Marton Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Oct 2022 25,099 25,099 - - Stock Option (right to buy)
David Diamond Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Oct 2022 25,099 25,099 - - Stock Option (right to buy)
Kirsten Angela Macfarlane Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Oct 2022 25,099 25,099 - - Stock Option (right to buy)
Angela Gill Nelms Chief Operating Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 19 Sep 2022 274,230 274,230 - - Employee Stock Option (right to buy)
Ramtin Agah Director, Chief Medical Officer, Ten Percent Owner Gift of securities by or to the insider at price $ 0.00 per share. 07 Jun 2022 975,000 1,295 - 0 Common Stock
Ramtin Agah Director, Chief Medical Officer, Ten Percent Owner Gift of securities by or to the insider at price $ 0.00 per share. 07 Jun 2022 975,000 975,000 - 0 Common Stock
Ramtin Agah Director, Chief Medical Officer, Ten Percent Owner Purchase of securities on an exchange or from another person at price $ 1.93 per share. 07 Jun 2022 5,182 6,477 - 1.9 10,001 Common Stock
Shaun R. Bagai Director, Chief Executive Officer Purchase of securities on an exchange or from another person at price $ 2.05 per share. 19 May 2022 5,500 251,557 - 2.1 11,275 Common Stock
Una S. Ryan Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 10 Mar 2022 4,582 4,582 - - Stock Option (right to buy)
Laurence J. Marton Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 10 Mar 2022 4,582 4,582 - - Stock Option (right to buy)
David Diamond Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 10 Mar 2022 9,165 9,165 - - Stock Option (right to buy)
David Diamond Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 10 Mar 2022 4,582 4,582 - - Stock Option (right to buy)
Shaun R. Bagai Director, Chief Executive Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 10 Mar 2022 48,313 48,313 - - Employee Stock Option (right to buy)
Ramtin Agah Director, Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 10 Mar 2022 21,398 21,398 - - Employee Stock Option (right to buy)
Kirsten Angela Macfarlane Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 10 Mar 2022 4,582 4,582 - - Stock option (right to buy)
Una S. Ryan Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Oct 2021 11,154 11,154 - - Stock Option (right to buy)
Kristen Angela Macfarlane Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Oct 2021 11,154 11,154 - - Stock Option (right to buy)
David Diamond Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Oct 2021 22,307 22,307 - - Stock Option (right to buy)
David Diamond Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Oct 2021 11,154 33,461 - - Stock Option (right to buy)
Laurence Marton Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Oct 2021 11,154 11,154 - - Stock Option (right to buy)
Ramtin Agah Director, Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 30 Sep 2021 52,203 52,203 - - Employee Stock Option (right to buy)
Shaun R. Bagai Director, Chief Executive Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 30 Sep 2021 117,866 117,866 - - Employee Stock Option (right to buy)
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc  
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges
View All The Insider Trades disclosures
Screeners based on Insider Trading and SAST parameters